Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Importance of hematocrit for a tacrolimus target concentration strategy.

European journal of clinical pharmacology - 1 Jan 2014

Størset Elisabet, Holford Nick, Midtvedt Karsten, Bremer Sara, Bergan Stein, Åsberg Anders

Abstract excerpt

PURPOSE: To identify patient characteristics that influence tacrolimus individual dose requirement in kidney transplant recipients. METHODS: Data on forty-four 12-h pharmacokinetic profiles from 29 patients and trough concentrations in 44 patients measured during the first 70 days after transplantation (1,546 tacrolimus whole blood concentrations) were analyzed. Population pharmacokinetic modeling was performed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Availability
Share to Cytochrome P-450 CYP3A

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hematocrit

Share to Immunosuppressive Agents

Share to Kidney Transplantation

Share to Models, Biological

Share to Tacrolimus

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 24071959
DOI: 10.1007/s00228-013-1584-7
PMCID: PMC3889505

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Importance of hematocrit for a tacrolimus target concentration strategy.PMID 24071959Read ↗

A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus Following Pediatric Renal Transplantation.Semantic proximity Read ↗

Population pharmacokinetics of tacrolimus in adult kidney transplant patients: impact of CYP3A5 genotype on starting dose.Semantic proximity Read ↗

In vivo CYP3A4 activity, CYP3A5 genotype, and hematocrit predict tacrolimus dose requirements and clearance in renal transplant patients.Semantic proximity Read ↗

Inclusion of CYP3A5 genotyping in a nonparametric population model improves dosing of tacrolimus early after transplantation.Semantic proximity Read ↗

The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant Recipients.Semantic proximity Read ↗

Determination of the most influential sources of variability in tacrolimus trough blood concentrations in adult liver transplant recipients: a bottom-up approach.Semantic proximity Read ↗

Improved prediction of tacrolimus concentrations early after kidney transplantation using theory-based pharmacokinetic modelling.Semantic proximity Read ↗

Population Pharmacokinetic Models of Tacrolimus in Adult Transplant Recipients: A Systematic Review.Semantic proximity Read ↗

A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population Approach.Semantic proximity Read ↗

CYP3A5 genotyping-guided dosing versus weight-based dosing in a multi-ethnic population of kidney transplant recipientsSemantic proximity Read ↗

[Pharmacogenetics of tacrolimus: from bench to bedside?].Semantic proximity Read ↗

A population pharmacokinetic model for early follow-up dosing of tacrolimus in Tunisian kidney transplant recipients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.